Enzychem Lifesciences
Ki-Young Sohn (Chairman & Chief Executive Officer)
Hye-Kyung Kim (Vice Chairman)
Sang-Gon Ko (Director)
Summary
History
In August 1998, Enzychem was established as a research-focused pharmaceutical company with a focus on developing innovative medicines through innovative research. Enzychem began its operation in Incheon, South Korea and was listed on the Korean Exchange in 2003. Since that time, Enzychem has grown to become a leader in the Korean pharmaceutical industry, becoming the first company to receive GMP certification from the Ministry of Food and Drug Safety in 2016.
Mission
Vision
Key Team
Jeffrey Crawford (Chairman of Scientific Advisory Board)
John Choi (Executive Director)
Do-Young Lee (Chief Scientific Officer & Member of the Board of Directors)
Myung-Hwan Kim (CMO & Director)
Alexander Fleming (Member of Corporate Advisory Committee & CTO)
Jae-Yong Lee (VP & Executive Director)
Frank Castellana (Member of Corporate Advisory Committee)
Woo Joo Kim (Member of Scientific Advisory Board)
David Grdina (Member of Scientific Advisory Board)
Michael Charlton (Member of Scientific Advisory Board)
Cecil Czerkinsky (Member of Scientific Advisory Board)
Jae-Wha Kim (Member of Scientific Advisory Board)
Larry W. Kwak (Member of Scientific Advisory Board)
Stephen T. Sonis (Member of Scientific Advisory Board)
Cameron Wolfe (Member of Scientific Advisory Board)
Sang-Hee Kim (Director)
Jong-Koo Kang (Director)
Recognition and Awards
References
Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.
Ki-Young Sohn (Chairman & Chief Executive Officer)
Hye-Kyung Kim (Vice Chairman)
Sang-Gon Ko (Director)